Addressing the Doctor Deficit in Hong Kong
Hong Kong boasts some of Asia’s finest universities, with five ranking in the global top 100, and its two medical schools – at the University of Hong Kong (HKU) and…
At Sanwa BioTech, we believe that impending changes are coming to the way to conventional clinical diagnostic & academic R&D for bio-discoveries. We aim to become a driving force for these changes to revolutionize healthcare solutions into the future. Sanwa BioTech delivers accurate and actionable information through our disposable Lab-On-Chip (LOC) rapid diagnostic platform, resulting in transformative diagnostic tests for faster clinical decisions and better economic outcomes.
At Sanwa Biotech, we provide diagnostic solutions based on our microfluidic disposable Lab-On-Chip (LOC) platform, including an integrative point of care device, reagents, software analytics & data management service, which brings convenience and value in diseases monitoring and supports clinical decisions, improves patients health and contributes to innovative solutions that combat challenges on global health care.
Contact
Unit 627, 6/F, BioTech Centre Two,
No.11 Science Park West Avenue,
Hong Kong Science Park,
Shatin, Hong Kong SAR,
CHINA
Unit 2, 5/F.,
Wah Lai Industrial Centre,
10-14 Kwei Tei Street,
Fo Tan, Hong Kong SAR,
CHINA
Tel: +852 2698 9903
Website: http://sanwabiotech.com/en/index.html
Email: inquiry@sanwabiotech.com
Hong Kong boasts some of Asia’s finest universities, with five ranking in the global top 100, and its two medical schools – at the University of Hong Kong (HKU) and…
Hong Kong needs to capitalise on its strong fundamentals to establish itself as a clinical research hotspot within APAC and support its transition into China’s innovation and technology hub. Does…
Billed as China’s attempt to create an economic powerhouse to rival Silicon Valley, ‘The Greater Bay Area’ is a mega-region that includes nine cities in Guangdong province plus the Special…
Professor at the Chinese University of Hong Kong since 1993 and pioneer in studying the causes of stroke in China, Lawrence Wong comments on neurology advancements over the past 30…
Chuen Yan Leung leads life science-focused venture capital firm Silver Dart Capital based out of Hong Kong and also serves as vice chairman of the Hong Kong Biotechnology Organization. In…
With its dual business approach – commercializing acquired products while developing a novel respiratory disease pipeline – Nuance Pharma, after closing Series D funding and establishing a solid revenue stream,…
Prominent oncologist and chair of the clinical oncology department at the Chinese University of Hong Kong Professor Tony Mok comments on the potential of the Antibody Drug Conjugates (ADC) platform…
Dr Jeremy Teoh highlights the importance of Hong Kong’s role in global urology research, emphasizing collaborations with international institutions and the Greater Bay Area. Despite the challenges of Hong Kong’s…
The GBA Healthcare Group aims to provide accessible, affordable, and accountable healthcare in the Greater Bay Area through a public-private partnership model, focusing on primary healthcare and health insurance empowerment.…
Professor Justin Che-Yuen WU outlines how strategic collaborations in the Greater Bay Area are expanding CUHK’s influence in medical innovation, healthcare services, and clinical research. Professor Wu explains how these…
Former Hong Kong SAR Chief Executive CY Leung discusses Hong Kong’s unique positioning within the Greater Bay Area and the importance of its openness, international business mindset, and strong sense…
Prof. Lo Chung-mau, Hong Kong’s Secretary for Health, delves into some of the key strategic initiatives for advancing Hong Kong’s healthcare and biomedical innovation. Key topics include the integration of…
See our Cookie Privacy Policy Here
